Friday, December 29, 2023 11:34:57 AM
Night has lost a lot of credibility over the last 3 years.
Mainly because he put out all those PR's and NEVER followed though.
Add in the lack of any significant change in revenue during that same period and you have a Missouri situation (Don't tell me show me)
Lucky for shareholders over the last 6 months there are things that can be seen.
- locations registered with the FDA
- new product listed with the FDA
- modernized website
- acquisition of ABBIE
The only thing left IS TO SHOW they can generate revenue then the stock price will take care of itself.
Mainly because he put out all those PR's and NEVER followed though.
Add in the lack of any significant change in revenue during that same period and you have a Missouri situation (Don't tell me show me)
Lucky for shareholders over the last 6 months there are things that can be seen.
- locations registered with the FDA
- new product listed with the FDA
- modernized website
- acquisition of ABBIE
The only thing left IS TO SHOW they can generate revenue then the stock price will take care of itself.
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
